Garuda - Garba Rujukan Digital

p-Index From 2020 - 2025

1.978

P-Index

This Author published in this journals

All Journal Jurnal Farmasi Klinik Indonesia Majalah Obat Tradisional INDONESIAN JOURNAL OF PHARMACY Panrita Abdi - Jurnal Pengabdian pada Masyarakat Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Majalah Farmasi dan Farmakologi (Trends in Pharmacy and Pharmaceutical Sciences) Jurnal farmasi UIN Alauddin Makassar Narra J Journal of Experimental and Clinical Pharmacy (JECP)

Elly Wahyudin

Department Of Pharmacy, Faculty Of Pharmacy, Universitas Hasanuddin, Makassar

Author-ID : 3371432

Biochemistry, Genetics & Molecular Biology Chemistry Dentistry Health Professions Immunology & microbiology Materials Science & Nanotechnology Medicine & Pharmacology Neuroscience Nursing Public Health Other

Published : 22 Documents Claim Missing Document

Claim Missing Document

Articles

1 2 3

EFEKTIVITAS PENGGUNAAN MgSO4 SEBAGAI TOKOLITIK PADA ANCAMAN PERSALINAN PREMATUR DI RSUP DR. WAHIDIN SUDIROHUSODO Nurhikma A; Elly Wahyudin; Nasruddin AM
Majalah Farmasi dan Farmakologi Vol. 21 No. 3 (2017): MFF
Publisher : Faculty of Pharmacy, Hasanuddin University

Penelitian ini dilakukan di Rumah Sakit Dr. Wahidin Sudirohusodo Makassar. Rumah Sakit Umum Daerah Labuang Baji, RSIA Sitti Khadijah, dan Klinik Sitti Khadijah Makassar dari Mei hingga Juli 2017 bertujuan menguji efektifitas penggunaan obat MgSO4 sebagai tokolitik pada pasien dengan ancaman persalinan prematur di Makassar. Terdapat 32 pasien yang terdaftar dalam penelitian. Jenis penelitian ini merupakan penelitian observasional dengan mengikuti rancangan deskriptif analitik dan pengambilan data secara prospektif. Hasil penelitian ini adalah dari 32 pasien yang mendapat terapi MgSO4, 2 orang yang berhasil menunda persalinan prematur dalam waktu 2x24 jam pada pemberian terapi ke 2 tanpa kontraksi, 21 pasien yang berhasil menunda persalinan prematur dalam waktu 2x24 jam pada pemberian terapi ke 3 tanpa kontraksi, 6 pasien yang berhasil menunda persalinan dengan penurunan kontraksi tersisa 1x10 menit (15-20 detik) dan 5 pasien yang berhasil menunda persalinan dengan penurunan kontraksi tersisa 1x10 menit (10-15 detik) masing-masing pada pemberian terapi ke 3. Dari hasil tersebut dapat disimpulkan bahwa, efektifitas MgSO4 dalam menunda persalinan prematur dalam waktu 2x24 jam adalah sebesar 71.87%.

AKTIVITAS ANTI DIABETES MELLITUS TANAMAN DURIAN (Durio zibethinus Murr.) TERHADAP KADAR GLUKOSA DARAH PUASA MENCIT YANG DIINDUKSI ALOKSAN Muh. Nur Amir; Yuyun Sulitiani; Indriani Indriani; Inda Pratiwi; Elly Wahyudin; Marianti A Manggau; Sumarheni Sumarheni; Ismail Ismail
Majalah Farmasi dan Farmakologi Vol. 23 No. 3 (2019): MFF
Publisher : Faculty of Pharmacy, Hasanuddin University

Durian (Durio zibethinus Murr.) telah lama digunakan sebagai salah satu pengobatan tradisional untuk mengobati berbagai macam penyakit, termasuk untuk penderita diabetes mellitus. Penelitian ini bertujuan untuk menentukan aktivitas ekstrak etanol durian dalam menurunkan kadar glukosa darah pada mencit yang diinduksi aloksan dosis 125 mg / kgBB dan diberi beban glukosa 20%. Sebanyak 36 ekor mencit dibagi menjadi 6 kelompok perlakuan. Kelompok I sebagai kontrol sehat, kelompok II diinduksi dengan aloksan dan diberikan NaCMC 1% (kontrol negatif), kelompok III diinduksi dengan aloksan dan diberikan Acarbose® (kontrol positif), kelompok IV diinduksi dengan aloksan dan diberikan ekstrak etanol akar durian (EDR), ekstrak klika (ESB) dan ekstrak daun (EDL) dosis 125 mg / kgBB, kelompok V diinduksi dengan aloksan dan diberikan ekstrak etanol akar durian (EDR), ekstrak klika (ESB) dan ekstrak daun (EDL) dosis 250 mg / kgBB, kelompok VI diinduksi dengan aloksan dan diberikan ekstrak etanol akar durian (EDR), ekstrak klika (ESB) dan ekstrak daun (EDL) dosis 500 mg / kgBB. Pengukuran kadar glukosa darah dilakukan sebelum induksi alloxan (t-0), 3x24 jam setelah induksi (t-3), dan setiap 30 menit setelah pemberian perlakuan ekstrak dan larutan glukosa hingga menit ke-180 (t30, t60, t90, t120, t150 dan t180), yang dilakukan pengukuran menggunakan alat glukometer (Nesco®). Persen penurunan kadar glukosa darah yang paling tinggi ditunjukkan setelah menit ke-180 pada kelompok EDR dengan dosis 125 mg / kgBB, ESB dosis 250 mg / kgBB dan EDL dosis 500 mg / kgBB yaitu sebesar 50,60%, 105,62%, dan 62,97%.

Effectiveness and Safety of Baricitinib as a Covid-19 Drug Candidate: A Systematic Review Yayuk S. Rahayu; Andi Anggriani; Habibie Habibie; Elly Wahyudin; Muhammad A. Bahar
Indonesian Journal of Clinical Pharmacy Vol 11, No 1 (2022)
Publisher : Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.15416/ijcp.2022.11.1.78

Baricitinib is an approved selective JAK1/JAK2 inhibitor that can potentially inhibit IL-6 as the primary driver of COVID-19-related cytokine storm syndrome. Therefore, this study aimed to assess the effectiveness and safety of baricitinib therapy in COVID-19 patients. It was reported following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The search for eligible articles reporting the efficacy and safety of baricitinib on COVID-19 patients, published up to May 2021, was conducted using PubMed and Embase. The research protocol was registered at PROSPERO (CDR42021235282), and data were presented in a metasynthetic (descriptive) manner. Out of 878 identified articles, seven were eligible and consisted of three randomized clinical trials, one quasi-experimental study, two before-after (pre-post) studies, and one cross-sectional study. The articles suggested that baricitinib could improve the clinical conditions of COVID-19 patients indicated by negative PCR test results, improve breathing quality, and decrease: ICU requirements, length of hospital stay, as well as the risk of death. The trial studies showed that this inhibitor works better with a loading dose of 8 mg, continued with 4 mg daily. Baricitinib could also produce synergistic effects with standard therapy such as corticosteroid and remdesivir. Therefore, it is a promising candidate therapy for COVID-19 patients, but since the number and methodological quality of the studies are low, further and better research is needed to ascertain its potential use on COVID-19. Keywords: Baricitinib, COVID-19, JAK1/2 inhibitor Efektivitas dan Keamanan Baricitinib sebagai Kandidat Obat Covid-19: Tinjauan SistematisAbstrakBaricitinib adalah inhibitor selektif JAK1 JAK2 yang dapat menghambat IL-6 sebagai pemicu utama terjadinya sindrom badai sitokin terkait COVID-19. Tinjauan sistematis ini dilakukan untuk menilai efektivitas dan keamanan terapi baricitinib pada pasien COVID-19. Kami melaporkan penelitian ini dengan mengikuti pedoman Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA). Kami menggunakan mesin pencari PubMed dan Embase untuk mencari artikel yang melaporkan efektivitas dan keamanan baricitinib pada pasien COVID-19, yang diterbitkan hingga Mei 2021. Protokol penelitian ini telah terdaftar di PROSPERO (CDR42021235282). Data disajikan secara metasintetik (deskriptif). Di antara 878 artikel yang teridentifikasi, ada tujuh artikel yang memenuhi syarat yang terdiri dari tiga artikel uji klinis acak terkendali, satu studi kuasi-eksperimental, dua studi sebelum-sesudah (pra-pasca) dan satu studi cross-sectional. Semua artikel menyatakan bahwa baricitinib dapat memperbaiki kondisi klinis pasien COVID-19 yang ditunjukkan dengan hasil tes PCR negatif, meningkatkan kualitas pernapasan, dan menurunkan: kebutuhan ICU, lama rawat inap, dan resiko kematian. Baricitinib tidak menyebabkan efek samping yang serius. Hasil uji klinis menunjukkan bahwa baricitinib bekerja lebih baik dengan pemberian loading dose 8 mg lalu dilanjutkan dengan baricitinib 4 mg setiap hari dibandingkan tanpa loading dose baricitinib. Baricitinib juga menghasilkan efek sinergistik jika dikombinasikan dengan terapi standar seperti kortikosteroid dan remdesivir. Oleh karena itu, dapat disimpulkan bahwa baricitinib adalah kandidat terapi yang menjanjikan untuk pasien COVID-19. Namun, karena jumlah dan kualitas metodologi penelitiannya rendah, penelitian lebih lanjut dan lebih baik secara metodologi masih dibutuhkan untuk memastikan potensi penggunaan baricitinib pada COVID-19.Kata kunci: Baricitinib, COVID-19, inhibitor JAK1/2

HUBUNGAN TEKANAN DARAH SISTOLIK DENGAN KADAR HBA1C PADA PASIEN HIPERTENSI DAN DIABETES MELLITUS TYPE 2 DI RS UNHAS MAKASSAR Hasteti Husni -; Elly Wahyudin; Hasyim Kasim
Majalah Farmasi dan Farmakologi Vol. 26 No. 2 (2022): MFF
Publisher : Faculty of Pharmacy, Hasanuddin University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20956/mff.v26i2.20482

Hipertensi adalah komorbiditas umum pada pasien diabetes mellitus, dengan prevalensi hingga dua pertiga dari populasi. Hipertensi ditemukan 1,5 sampai 3 kali lebih sering pada penderita diabetes mellitus. Penelitian ini bertujuan untuk mengetahui hubungan antara tekanan darah sistolik dengan kadar HbA1c pada pasien hipertensi dan diabetes mellitus di Instalasi Rawat Inap RS UNHAS Makassar periode 2019-2020. Penelitian ini merupakan penelitian non eksperimental yang dilakukan dengan metode deskriptif menggunakan data retrospektif berupa penelusuran data rekam medis pasien hipertensi dan diabetes mellitus yang memilki data pemeriksaan tekanan darah dan kadar HbA1c. Subjek penelitian dipilih dari populasi terjangkau yang memenuhi kriteria inklusi yakni sebanyak 56 sampel. Pada penelitian ini didapatkan distribusi frekuensi jenis kelamin meliputi 35 orang (62,5%) perempuan dan 21 orang (37,5%) laki-laki. Distribusi frekuensi jumlah kelompok usia terbanyak yakni pada rentang 45-64 tahun yakni sebanyak 30 orang (56,6%), usia >65 tahun sebanyak 17 orang (30,4%), dan usia 26-45 tahun sebanyak 9 orang (16,1%). Distribusi frekuensi tekanan darah sistolik pada pasien hipertensi dengan diabetes mellitus tipe 2 dengan tekanan darah normal <140 mmhg yakni sebanyak 21 orang (41,1%), dan pasien dengan tekanan darah >140 mmhg yakni sebanyak 33 orang (58,9%). Distribusi frekuensi kadar HbA1c dengan kategori baik <6,5 yakni 4 orang (7,1%), kategori sedang 6,5-8 yakni 17 orang (30,4%), dan kategori buruk >8 yakni sebanyak 35 orang (62,5%). Hasil analisis data menggunakan rumus chi-square dengan uji alternatif fisher exact melalui cross tabulasi dengan tingkat kesalahan (alpha) 0,05 didapatkan P value = 0,789 (P>0.05), maka dapat disimpulkan bahwa tidak ada hubungan yang signifikan antara tekanan darah sistolik dengan kadar HbA1c pada pasien hipertensi dan diabetes mellitus tipe 2.

Efek Asam Askorbat Menurunkan Indeks Aterogenik dan Kadar Gula Darah Tikus (Rattus norvegicus L.) Diabetes Mellitus Induksi Aloksan Sunarti, Sunarti; Wahyudin, Elly; Kasim, Hasyim
Journal of Experimental and Clinical Pharmacy (JECP) Vol 2, No 1 (2022): February 2022
Publisher : Poltekkes Kemenkes Gorontalo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52365/jecp.v2i1.303

Senyawa antioksidan diketahui dapat meningkatkan indeks aterosklerosis dan sekresi insulin. Penelitian ini bertujuan untuk mengetahui peran asam askorbat sebagai pengatur aterosklerosis dan kadar gula darah pada kondisi diabetes (DM). Rancangan penelitian yang digunakan adalah penelitian eksperimental dengan menggunakan 20 ekor tikus putih jantan (Rattus norvegicus L.) dengan berat badan 180-300 g, umur 23 bulan, sebagai hewan percobaan. Setelah aklimatisasi selama satu minggu, tikus tidak diberi makan semalaman dan keesokan harinya diinduksi aloksan dengan dosis 145 mg/kg berat badan (BB). Tiga hari kemudian, darah diambil melalui vena ekor tikus untuk menguji gula darah. Indeks arteriosklerosis (AI) ditentukan dengan rumus (kolesterol HDL total)/HDL. Sebagai hewan percobaan, tikus dengan kadar glukosa darah 200 mg/dl atau lebih dipilih dan dibagi menjadi 4 kelompok yang masing-masing terdiri dari 5 ekor tikus. kelompok I pakan standar; Kelompok II mendapat diet standar majemuk dan metformin; Kelompok III diberi diet standar dan asam askorbat dan kelompok IV diberi diet standar dan kombinasi metformin dan asam askorbat. Pada awal diabetes, berat tikus dikurangi dari 240 g menjadi 220 g. Namun, setelah 2 minggu terapi asam askorbat, berat badan stabil, gula darah turun 65,57 dan 324,94 mg/dl menjadi 111,88 mg/dl, dan indeks arteriosklerosis menurun dari 0,324 menjadi 0,320.Antioxidant compounds are known to increase atherosclerosis index and insulin secretion. This study aims to determine the role of ascorbic acid as a regulator of atherosclerosis and blood sugar levels in diabetes (DM). The research design used was an experimental study using 20 male white rats (Rattus norvegicus L.) with a body weight of 180-300 g and 23 months of ageas experimental animals. After acclimatization for one week, the rats were not fed overnight and the next day the rats were induced with alloxan at a dose of 145 mg/kg body weight (BW). Three days later, the blood was drawn through the tail vein of the rats to test for blood sugar. The arteriosclerosis index (AI) was determined by the formula (total HDL cholesterol)/HDL. As experimental animals, rats with blood glucose levels of 200 mg/dl or more were selected and divided into 4 groups of 5 rats each. group I standard feed; Group II received a standard compound diet and metformin; Group III was given a standard diet and ascorbic acid and group IV was given a standard diet and a combination of metformin and ascorbic acid. At the onset of diabetes, the weight of the rats was reduced from 240 g to 220 g. However, after 2 weeks of ascorbic acid therapy, body weight was stable, blood sugar decreased from 65.57 and 324.94 mg/dl to 111.88 mg/dl, and the arteriosclerosis index decreased from 0.324 to 0.320.

A fruit fly-based approach to unraveling enteropathy-causing pharmaceuticals Pratama, Muhammad R.; Wahyudin, Elly; Putri, Tenri ZAD.; Hardiyanti, Widya; Fatiah, Dewita; Chaeratunnisa, Rizkya; Bapulo, Nurdewi N.; Latada, Nadila P.; Mudjahid, Mukarram; Nainu, Firzan
Narra J Vol. 4 No. 2 (2024): August 2024
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v4i2.898

Enteropathy is a gastrointestinal disorder characterized by inflammation in the small intestine and one of the causes of enteropathy is the side effects of certain drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs). The mechanism of NSAIDs, such as indomethacin, could inhibit prostaglandin synthesis, leading to a decrease in mucus production and small intestine integrity. To test the effects of a drug, it is necessary to undergo preclinical testing using animal models. Commonly used animal models such as mice and rats have several drawbacks including high cost, ethical issues, and long lifespan. Therefore, alternatives such as using invertebrate animals like Drosophila melanogaster as a more economical in vivo platform with genetic similarity to mammals and devoid of ethical concerns are needed. The aim of this study was to evaluate Drosophila melanogaster as an in vivo model organism in testing the side effects of pharmaceuticals that cause enteropathy. In this study, flies aged 3–5 days were starved and then placed into treatment vials comprising untreated control and indomethacin-treated (3.75 mM, 7.5 mM, and 15 mM). Survival analysis was conducted during the treatment period, followed by a Smurf assay test after seven days of treatment. Subsequently, the expression of pro-inflammatory cytokine-related genes (drs and totA), mitochondria stability-related genes (tom40), and endogenous antioxidant-related genes (sod1, sod2, and cat) was performed using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Our data indicated that indomethacin did not impact lifespan or cause intestinal damage. However, we observed increased expression of pro-inflammatory cytokine-related genes, including drs, and a twofold increase in totA gene expression. Furthermore, there was a significant upregulation of mitochondrial stability gene tom40, endogenous antioxidant genes sod1 and cat, and a threefold increase in sod2 at 15 mM indomethacin. Although no phenotypical changes in gut integrity were detected, the increased expression of pro-inflammatory cytokine genes suggests the occurrence of inflammation in the indomethacin-treated flies.

Effects of Combination of Cisplatin and Paclitaxel Chemotherapy on Tumor Mass in Nasopharyngeal Carcinoma Patients at Dr. Wahidin Sudirohusodo Hospital Makassar with the RECIST Method: Efek Kombinasi Kemoterapi Cisplatin dan Paclitaxel Terhadap Massa Tumor pada Pasien Karsinoma Nasofaring di RSUP Dr. Wahidin Sudirohusodo Makassar dengan Metode RECIST Hakim, Azima; Wahyudin, Elly; Pieter, Nova Audrey Luetta
Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) Vol. 9 No. 2 (2023): (October 2023)
Publisher : Universitas Tadulako

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22487/j24428744.2023.v9.i2.16236

Background: Nasopharyngeal Carcinoma (NPC) is a malignant tumor that grows from epithelial cells that line the surface of the nasopharynx and has a tumor position close to the base of the skull, vital structures, and anatomical locations that are difficult to reach and various symptoms are the cause of increased patient mortality and morbidity rates. This research aims to identify the most effective chemotherapy effect on reducing tumor mass in nasopharyngeal cancer patients. Material and Methods: This study was conducted retrospectively based on patient medical record data from January 2019 to December 2021 at Dr. Wahidin Sudirohusodo General Hospital. Inclusion criteria included NPC patients who received cisplatin, carboplatin, paclitaxel, and docetaxel chemotherapy and had complete data on tumor mass size before and after receiving chemotherapy from Series I to Series VI. The resulting assessment of tumor mass size was further categorized using RECIST. Results: A total of 166 NPC patients met the inclusion criteria. The results of the study obtained that NPC patients suffered more in men than women, most NPC patients were aged (41-50), Stage IVA had the highest percentage found in NPC patients, Histopathology based on WHO type III was most commonly found in 109 patients, 70 patients used the Cisplatin+Paclitaxel chemotherapy regimen, 55 patients used the Cisplatin+Paclitaxel chemotherapy regimen had a partial tumor mass response. Conclusions: The combination of Cisplatin + Paclitaxel has the most partial response to the tumor mass of NPC patients at Wahidin Sudirohusodo General Hospital, Makassar.

Undernutrition-induced stunting-like phenotype in Drosophila melanogaster Putri, Tenri ZAD.; Wahyudin, Elly; Pratama, Muhammad R.; Fatiah, Dewita; Hardiyanti, Widya; Chaeratunnisa, Rizkya; Latada, Nadila P.; Fatmawati, Fatmawati; Mudjahid, Mukarram; Nainu, Firzan
Narra J Vol. 4 No. 3 (2024): December 2024
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v4i3.999

Stunting resulting from undernutrition is a significant global health challenge, particularly in developing countries, yet its underlying mechanisms and consequences remain inadequately understood. This study utilizes Drosophila melanogaster as an in vivo model to investigate the molecular basis of stunting. Due to the conserved nature of signaling pathways between Drosophila and vertebrates, this organism serves as an effective model for studying growth disorders. The aim of this study was to establish a Drosophila model exhibiting a stunting-like phenotype and to elucidate the molecular mechanisms underlying this condition. The stunting phenotype was induced through dietary manipulation, involving a standard nutrient-rich diet (100%) and treatment diets with reduced concentrations of sucrose, glucose, yeast, and cornmeal at 50%, 25%, and 12.5%. Phenotypic assessments included measurements of larval body size, fecundity, survival rates, and locomotor activity, alongside molecular analyses of gene expression related to metabolism, cell proliferation, and survival, using RT-qPCR. Results demonstrated that undernutrition profoundly affected D. melanogaster, causing growth retardation, reduced larval body size, diminished fecundity, and lower survival rates, though locomotor function remained unaffected. Molecular analysis revealed a significant decrease in the expression of the totA gene and notable increases in the expression of dilp5, srl, and indy genes, with no significant changes observed in the expression of the pepck gene. These findings indicate that undernutrition induces a stunting-like phenotype, likely driven by alterations in the expression of genes associated with metabolism, cell proliferation, and survival. Overall, this study establishes D. melanogaster as a valuable in vivo model for studying stunting-like phenotypes resulting from nutritional deficiencies and provides insights into the molecular pathways involved in growth impairment.

KOMPAK: Translation, cross-cultural adaptation, and validation of an instrument for assessing interprofessional collaboration between pharmacists and physicians in Indonesia Amin, Irnawati H.; Massi, Muhammad N.; Wahyudin, Elly; Bahar, Muhammad A.; Hadju, Veni; Niamuzisilawati, Eva; Munawwaroh, Makiyatul; Utami, Ikrimah N.; Ardiansyah, Akhmad; Alkaff, Sylmina D.; Arifin, Bustanul
Narra J Vol. 5 No. 1 (2025): April 2025
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v5i1.1309

Interprofessional collaboration is crucial for addressing the complexity of health problems, requiring contributions from various professions to enhance healthcare quality, improve patient satisfaction, and achieve better clinical outcomes. The aim of this study was to develop and validate the physicians and pharmacists collaborative practice instrument, known as KOMPAK (Kolaborasi Medis Persepsi Apoteker dan Dokter/Medical Collaboration: Perceptions of Pharmacists and Physicians) for use in Indonesia. A cross-sectional study was conducted across the western, central, and eastern rigors of Indonesia, targeting physicians and pharmacists. The study included translation (forward and backward), cross-cultural adaptation (with 30 participants), and validation using confirmatory factor analysis (CFA) among 315 physicians and 315 pharmacists. The present study found no significant changes emerged during the translation and adaptation phases. In the validation phase, the CFA results for the physician instrument indicated a Comparative Fit Index (CFI) of 0.94 (>0.92), Tucker-Lewis Index (TLI) of 0.93 (>0.92), Root Mean Squared Error of Approximation (RMSEA) of 0.055 (<0.07), Standardized Root Mean Residual (SRMR) of 0.07 (<0.08), and Cronbach’s Alpha reliability of 0.88. The pharmacist instrument yielded similar results with a CFI of 0.94 (>0.92), TLI of 0.93 (>0.92), RMSEA of 0.06 (<0.07), SRMR of 0.05 (<0.08), and Cronbach’s Alpha reliability of 0.83. The final instrument consists of 24 items. In conclusion, the KOMPAK instrument demonstrated validity and reliability, supporting its use for measuring interprofessional collaboration between physicians and pharmacists in Indonesia.

Chemical fingerprinting and antioxidant properties of Glochidion philippicum Khairuddin, Khairuddin; Manggau, Marianti A.; Rante, Herlina; Hardiyanti, Widya; Latada, Nadila P.; Umar, Abdul H.; Nur, Syamsu; Wahyudin, Elly; Rahman, Latifah; Yulianty, Risfah; Nainu, Firzan
Narra J Vol. 5 No. 1 (2025): April 2025
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v5i1.1886

Glochidion philippicum has been suggested to exhibit considerable pharmacological potential, yet its chemical composition and bioactivity remain inadequately explored. The aim of this study was to investigate the chemical fingerprint and antioxidant properties of G. philippicum leaf extracts using Fourier-transform infrared spectroscopy (FTIR) with chemometric analyses, and in vitro and in vivo evaluations. Four extraction methods (maceration, reflux, ultrasound-assisted extraction (UAE), and microwave-assisted extraction (MAE)) were optimized with water, 70% ethanol, ethyl acetate, and n-hexane as solvents. FTIR profiles were analyzed with principal component analysis (PCA), hierarchical cluster analysis, and orthogonal partial least squares discriminant analysis. An in vitro study assessing the free radical scavenging capacity was conducted using the 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH), and ferric-reducing antioxidant power (FRAP) methods, while in vivo evaluations were conducted using Drosophila melanogaster to measure antioxidant enzyme activity and expression of endogenous antioxidant-related genes. FTIR profiles identified functional groups contributing to antioxidant activity. In vitro assays using ABTS and FRAP methods revealed that extracts obtained with 70% ethanol and water exhibited the highest antioxidant activity, attributed to key functional groups such as C=C (aromatic), O−H (acidic), N=O (nitro), and C−O (ester). In vivo studies showed that ethanol-based MAE extracts (MAEEO) significantly improved the survival of autoinflammatory PGRP-LBΔ mutant larvae exposed to heat-killed Escherichia coli. Real-time quantitative PCR analysis indicated this effect was dependent on endogenous antioxidant gene activation. The study highlights that G. philippicum leaf extracts as a natural source of bioactive compounds with exogenous antioxidant properties, offering potential for therapeutic applications.

Co-Authors . Lukman . Mufidah . Subehan A. Prasetiyo, Nugraha Ahmad Fuady Aisyah Fatmawaty Aliyah Aliyah Alkaff, Sylmina D. Amin, Irnawati H. Andi Anggriani Ardiansyah, Akhmad Arif Santoso Asniar Pascayantri Bahar, Muhammad A. Bapulo, Nurdewi N. Bustanul Arifin Chaeratunnisa, Rizkya Dewita Fatiah Dwi Leboe Ermina Pakki Fatmawati Fatmawati Firzan Nainu Gatot S Lawrence Gatot S. Lawrence Gemini Alam Habibie Habibie Hakim, Azima Hardiyanti, Widya Hasteti Husni - Herlina Rante Herlina Rante Iman Setiawan Inda Pratiwi Indriani Indriani Ismail Ismail Isriany Ismail Jumriani Tammas Kasim, Hasyim Khairuddin - Latada, Nadila P. Latifah Rahman Latifah Rahman M Natsir Djide M Rusdi M. Natsir Djide Madolangan, Jamaluddin Mae Sri Hartati Wahyuningsih Marianti A Manggau Massi, Muhammad N. Mirianti A. Manggau, Mirianti A. Mudjahid, Mukarram Mufidah Mufidah Muh. Akbar Bahar Munawarah Munawarah Munawwaroh, Makiyatul Nasruddin AM Niamuzisilawati, Eva Nurhikma A Pieter, Nova Audrey Luetta Pratama, Muhammad R. Purba, Fredrick D. Putri, Tenri ZAD. Risfah Yulianty Risfah Yulianty Risfah Yulianty Rosany tayeb Sanusi, Mayamariska Sarifah, Latifah M. Sartini Sartini Sarwadan, Muhamad G. Sri Yolandari Sumarheni Sumarheni Sunarti Syamsu Nur, Syamsu Tadjuddin Naid Tuti Handayani Zainal Umar, Abdul H. Utami, Ikrimah N. Veni Hadju Yayuk S. Rahayu Yulia Yusrini Djabir Yusnita Rifai Yuyun Sulitiani Zhulhajsyirah Zhulhajsyirah

Title

Found 22 Documents
Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title Search

Found 22 Documents Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title

Found 22 Documents
Search